Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-dose Glucagon for Exercise-induced Hypoglycemia in T1D
NCT02660242Phase 2Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jan 2016
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
A Phase 2 trial of G-Pen in type 1 diabetes mellitus (T1D), sponsored by Jaeb Center for Health Research. Started Jan 2016; status: completed.
02
Drugs
G-Pen
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02660242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660242.